Tag: medtech

[Scopio in PR Newswire] Study Reveals Faster Turnaround Time in Clinical Laboratory With Scopio Labs’ Remote Digital Morphology

TEL AVIV, Israel, April 27, 2023 /PRNewswire/ — Scopio Labs today announced the publication of a new study that examines the impact of implementing remote* digital microscopy for peripheral blood smear (PBS) analysis. Conducted by Tel Aviv Sourasky Medical Center (TASMC) and published in Applied Clinical Informatics, the study found that the application of Scopio’s digital imaging and analysis system significantly reduces laboratory turnaround time (TAT) for PBS review, as compared to TASMC’s previous digital morphology workflow. Read more...

Read More

[MeMed in GlobeNewswire] Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department

PETAH TIKVA, Israel and HAIFA, Israel; April 18, 2023 – MeMed, a leader in the emerging field of advanced host-response technologies, and Schneider Children’s Medical Center, the only comprehensive, tertiary care hospital of its kind in Israel, today announce that clinical data from the independent, prospective Rosetta study, recently published in PLOS One, showed that the MeMed BV test provides an accurate diagnosis of bacterial versus viral infection and reduces Emergency Department (ED) physician error. Read more...

Read More

[Firefly Neuroscience in GlobeNewswire] STALICLA and Firefly Neuroscience enter partnership agreement for the development of Electroencephalogram (EEG) as a biomarker for subgroups of patients with ASD

Geneva, Switzerland – 27 March 2023, STALICLA SA and Firefly Neuroscience today announced a partnership to further validate EEG-based biomarkers in biologically enriched subgroups of patients with Autism Spectrum Disorder (ASD). This follows the successful completion of STALICLA’s Phase 1b clinical trial for its lead asset STP1 where EEG measurement was shown to be a powerful predictor of efficacy. Read more...

Read More